Evolving International Guidelines for Rh Testing in the First Trimester - SC27

Saturday, May 20, 2023

2:15 PM – 3:15 PM ET

Location: Ballroom IV

CME Credits 1

Sub Topic: Evaluation/Diagnosis of Antenatal Conditions

Sarah Horvath (she/her/hers)

Assistant Professor
Penn State Hershey Medical Center

Disclosure(s): Organon: Honorarium (Ongoing)
Sarah W. Prager, MD (she/her/hers)

Professor
University of Washington
University of Washington
Seattle, WA, United States

Disclosure(s): UpToDate: Royalties (Ongoing)

Session Description
In 2022, the World Health Organization (WHO) recommended against Rh testing and Rh immunoglobulin administration for patients undergoing medication or procedural abortion prior to 12 weeks of gestation. Many other organizations, in the United States and elsewhere, have similarly changed guidance. This session will provide an overview of the changes and the evidence informing them.

Disclosure(s):

Sarah Horvath, MD, MS: Organon: Honorarium (Ongoing)

Sarah W. Prager, MD: UpToDate: Royalties (Ongoing)